neurodiversity m&a grows further

neurodiversity m&a grows further

The Biggest Lie About Mental Health Neurodiversity M&A

In 2024, Bridgepoint’s $1.3 billion acquisition of Kayne Anderson’s healthcare portfolio sparked headlines that claim the merger will transform neurodiversity care, but the truth is far less altruistic. Investors see the bundled real-estate and clinic model as a way to lock in cash flow, cut costs and